34682462|PMC8535397
{'Chemical', 'Disease', 'Species', 'Gene'}
Participation of pregnant women in clinical trials entails challenges mainly related to concerns about the risks for fetuses. Reasons given by participants are illustrated in Table 3.According to pregnant women's reasoning for accepting, or not, to participate in a clinical trial, several barriers and facilitators were identified and can be classified into individual, interpersonal, and trial-related factors, as shown in Table 4.Rejection to drug uptake during pregnancy and fears of adverse effects on the babies were pointed as the major reasons for refusing to participate in a clinical trial. Healthcare professionals explained that women often referred to "secondary effects related to the drug" as a barrier to participate in the trial.